Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.25.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 104 $ 58,721,538 $ (4,652) $ (35,318,538) $ 23,398,452
Balance (in Shares) at Dec. 31, 2023 1,041,582        
Balance at Mar. 31, 2024 $ 104 59,068,015 (5,272) (39,179,378) 19,883,469
Balance (in Shares) at Mar. 31, 2024 1,043,248        
Stock-based compensation:          
-restricted stock units 48,088 48,088
-restricted stock units (in Shares) 1,666        
-stock options 297,602 297,602
-warrants 787 787
Foreign currency translation (620) (620)
Net loss (3,860,840) (3,860,840)
Balance at Dec. 31, 2024 $ 139 64,372,486 (7,171) (49,582,778) 14,782,676
Balance (in Shares) at Dec. 31, 2024 1,394,263        
Balance at Mar. 31, 2025 $ 270 66,124,529   (53,146,016) $ 12,978,783
Balance (in Shares) at Mar. 31, 2025 2,705,263        
Stock-based compensation:          
-restricted stock units (in Shares)         1,666
-stock options 96,985 $ 96,985
-warrants 1,573 1,573
Issuance of common stock at-the-market for cash, net of offering costs $ 44 1,652,701 1,652,745
Issuance of common stock at-the-market for cash, net of offering costs (in Shares) 440,000        
Issuance of common stock from the exercise of pre-funded warrants, net $ 87 784 $ 871
Issuance of common stock from the exercise of pre-funded warrants, net (in Shares) 871,000      
Foreign currency translation 7,171 $ 7,171
Net loss $ (3,563,238) $ (3,563,238)